• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较多种机器学习模型在预测活体供肝移植婴儿患者他克莫司浓度方面的性能。

Compare the performance of multiple machine learning models in predicting tacrolimus concentration for infant patients with living donor liver transplantation.

作者信息

Song XueWu, Liu FangHao, Gao HuiEr, Yan MeiLing, Zhang FeiYu, Zhao Jia, Qin YinPeng, Li Yue, Zhang Yi

机构信息

First Central Clinical College of Tianjin Medical University, Tianjin, China.

College of Computer Science, Tianjin Key Laboratory of Network and Data Security Technology, Nankai University, Tianjin, China.

出版信息

Pediatr Transplant. 2023 Feb;27(1):e14379. doi: 10.1111/petr.14379. Epub 2022 Aug 30.

DOI:10.1111/petr.14379
PMID:36039686
Abstract

BACKGROUND

This study aims to establish multiple ML models and compare their performance in predicting tacrolimus concentration for infant patients who received LDLT within 3 months after transplantation.

METHODS

Retrospectively collected basic information and relevant biochemical indicators of included infant patients. CMIA was used to determine tacrolimus C . PCR was used to determine the donors' and recipients' CYP3A5 genotypes. Multivariate stepwise regression analysis and stepwise elimination covariates were used for covariates selection. Thirteen machine learning algorithms were applied for the development of prediction models. APE, the ratio of the APE ≤3 ng ml and ideal rate (the proportion of the predicted value with a relative error of 30% or less) were used to evaluate the predictive performance of the model.

RESULTS

A total of 163 infant patients were included in this study. In the case of the optimal combination of covariates, the Ridge model had the lowest APE, 2.01 (0.85, 3.35 ng ml ). The highest ratio of the APE ≤3 ng ml was the LAR model (71.77%). And the Ridge model showed the highest ideal rate (55.05%). For the Ridge model, GRWR was the most important predictor.

CONCLUSIONS

Compared with other ML models, the Ridge model had good predictive performance and potential clinical application.

摘要

背景

本研究旨在建立多个机器学习模型,并比较它们在预测移植后3个月内接受活体肝移植的婴儿患者他克莫司浓度方面的性能。

方法

回顾性收集纳入的婴儿患者的基本信息和相关生化指标。采用化学发光微粒子免疫分析(CMIA)测定他克莫司浓度。采用聚合酶链反应(PCR)测定供体和受体的CYP3A5基因型。采用多变量逐步回归分析和逐步剔除协变量进行协变量选择。应用13种机器学习算法建立预测模型。采用绝对百分比误差(APE)、APE≤3 ng/ml的比例和理想率(相对误差≤30%的预测值比例)评估模型的预测性能。

结果

本研究共纳入163例婴儿患者。在协变量的最佳组合情况下,岭回归模型的APE最低,为2.01(0.85,3.35 ng/ml)。APE≤3 ng/ml比例最高的是最小角回归(LAR)模型(71.77%)。岭回归模型的理想率最高(55.05%)。对于岭回归模型,肾小球滤过率加权回归(GRWR)是最重要的预测因子。

结论

与其他机器学习模型相比,岭回归模型具有良好的预测性能和潜在的临床应用价值。

相似文献

1
Compare the performance of multiple machine learning models in predicting tacrolimus concentration for infant patients with living donor liver transplantation.比较多种机器学习模型在预测活体供肝移植婴儿患者他克莫司浓度方面的性能。
Pediatr Transplant. 2023 Feb;27(1):e14379. doi: 10.1111/petr.14379. Epub 2022 Aug 30.
2
GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism.根据供体 CYP3A5 多态性,GRWR 与小儿活体肝移植后他克莫司的代谢相关。
Biomed Res Int. 2022 Oct 30;2022:7647754. doi: 10.1155/2022/7647754. eCollection 2022.
3
CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation.携带CYP3A5*1的移植肝脏降低了活体肝移植受者中环孢素的浓度/口服剂量比。
Pharmacogenetics. 2004 Jul;14(7):471-8. doi: 10.1097/01.fpc.0000114747.08559.49.
4
Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation.肝肠 CYP3A5 基因型组合对活体肝移植受者他克莫司药代动力学的影响。
Transplantation. 2012 Oct 27;94(8):866-72. doi: 10.1097/TP.0b013e318263700a.
5
Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients.供体及受体的CYP3A5基因分型对日本成年活体肝移植受体他克莫司药代动力学及感染性并发症的影响
Ann Transplant. 2011 Oct-Dec;16(4):55-62. doi: 10.12659/aot.882219.
6
Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.供体-受体CYP3A4/5基因分型、年龄及氟康唑对小儿肝移植中环孢素A药代动力学的影响:群体分析方法
Pharmacogenomics. 2014 Jun;15(9):1207-21. doi: 10.2217/pgs.14.75.
7
Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation.细胞色素 P450 3A5 多态性对活体肝移植供体肝脏中急性细胞排斥反应频率的影响。
Pharmacogenet Genomics. 2014 Jul;24(7):356-66. doi: 10.1097/FPC.0000000000000060.
8
CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation.受者而非供者的 CYP3A7、CYP3A4 和 CYP3A5 基因多态性影响肝移植后早期他克莫司的浓度。
Gene. 2022 Jan 30;809:146007. doi: 10.1016/j.gene.2021.146007. Epub 2021 Oct 22.
9
Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients.移植物肝 CYP3A5 基因型与活体肝移植患者类固醇治疗后他克莫司生物转化增加的关系。
Drug Metab Pharmacokinet. 2014;29(1):83-9. doi: 10.2133/dmpk.dmpk-13-rg-060. Epub 2013 Aug 13.
10
The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose-corrected trough concentration in the early period after liver transplantation.受体 SLCO1B1 rs2291075 多态性对肝移植后早期他克莫司剂量校正谷浓度的影响。
Eur J Clin Pharmacol. 2021 Jun;77(6):859-867. doi: 10.1007/s00228-020-03058-w. Epub 2021 Jan 2.

引用本文的文献

1
Analytical modelling techniques for enhancing tacrolimus dosing in solid organ transplantation: a systematic review protocol.分析建模技术在实体器官移植中增强他克莫司剂量的应用:系统评价方案
BMJ Open. 2024 Nov 1;14(10):e088775. doi: 10.1136/bmjopen-2024-088775.
2
Artificial Intelligence in Pediatric Liver Transplantation: Opportunities and Challenges of a New Era.人工智能在小儿肝移植中的应用:新时代的机遇与挑战
Children (Basel). 2024 Aug 15;11(8):996. doi: 10.3390/children11080996.